US Patent Issued to GI INNOVATION on Nov. 25 for "Pharmaceutical composition for enhancing radiotherapy comprising fusion protein containing IL-2 protein and CD80 protein" (South Korean Inventors)

ALEXANDRIA, Va., Nov. 25 -- United States Patent no. 12,478,675, issued on Nov. 25, was assigned to GI INNOVATION INC. (Seoul, South Korea).

"Pharmaceutical composition for enhancing radiotherapy comprising fusion protein containing IL-2 protein and CD80 protein" was invented by Myung Ho Jang (Seoul, South Korea), Su Youn Nam (Seoul, South Korea) and Young Jun Koh (Seoul, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "A pharmaceutical composition for enhancing radiation therapy, containing a fusion protein dimer is disclosed. The fusion protein dimer includes an IL-2 protein and a CD80 protein. A method of radiation therapy for cancer, using the composition is also disclosed. The composition for ...